Fenwick Represents Clarus Ventures in Leading $26.5M Series A Financing for Imago BioSciences

Fenwick & West LLP represented Clarus Ventures LLC, a global investment firm founded by a team of accomplished investment and operating professionals dedicated to life sciences, in leading its recently announced $26.5 million Series A financing for Imago BioSciences, Inc., a biotech company developing innovative therapeutics. Representatives from Clarus Ventures will join the company’s board of directors.

With the new funds, the company will continue to advance the research and clinical development program of therapeutics that alter gene expression patterns. Read more about Clarus Ventures’ Series A investment in Imago BioSciences.

The Fenwick transaction team was led by corporate partner Alan Smith and corporate associates Matthew Karwoski, Anna Szygorski and Esther Chan.


Don’t have an account yet?